Literature DB >> 23114545

[Management of anaphylaxis. Part 1: Causes and pathophysiology].

A Glowania1, U Goebel, L Klimek.   

Abstract

Anaphylactic reactions reveal the maximal grade of allergic reactions and are potentially life-threatening. The most common agents involved in anaphylactic reactions are drugs, food, Hymenoptera, aeroallergens, Latex, and physical stress. Anaphylactic reactions are induced by the liberation of various mediators. Symptoms are determined by the kind, quantity, and relation of these mediators and by the individual predisposition of the patient. In general, symptoms occur at the skin, the lungs, the cardiovascular system and the gastrointestinal tract. Early treatment of circulatory and pulmonary disturbances is decisive for the prognosis of the patient. Adequate therapy has to be given immediately according to the severity of symptoms in a step-wise approach. In the specific drug-therapy, a few substances have proved to be reliable, e.g. adrenalin, histamine antagonists, glucocorticosteroids, oxygen and volume substitutes. This article provides an overview of prevalence, symptoms and therapeutic options for managing anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114545     DOI: 10.1007/s00106-012-2579-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  12 in total

Review 1.  Adrenaline in the treatment of anaphylaxis: what is the evidence?

Authors:  Andrew P C McLean-Tooke; Claire A Bethune; Ann C Fay; Gavin P Spickett
Journal:  BMJ       Date:  2003-12-06

2.  Anaphylactic and anaphylactoid reactions during the perioperative period.

Authors:  V Lagopoulos; E Gigi
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

Review 3.  Epidemiology of anaphylaxis.

Authors:  Sunday Clark; Carlos A Camargo
Journal:  Immunol Allergy Clin North Am       Date:  2007-05       Impact factor: 3.479

Review 4.  Therapeutic controversies in the management of acute anaphylaxis.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1998-03

Review 5.  Epidemiology of life-threatening and lethal anaphylaxis: a review.

Authors:  D A Moneret-Vautrin; M Morisset; J Flabbee; E Beaudouin; G Kanny
Journal:  Allergy       Date:  2005-04       Impact factor: 13.146

6.  Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice.

Authors:  P M Mertes; J M Malinovsky; L Jouffroy; W Aberer; I Terreehorst; K Brockow; P Demoly
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

7.  World Allergy Organization anaphylaxis guidelines: summary.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

8.  The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

Authors:  Wyatt W Decker; Ronna L Campbell; Veena Manivannan; Anuradha Luke; Jennifer L St Sauver; Amy Weaver; M Fernanda Bellolio; Eric J Bergstralh; Latha G Stead; James T C Li
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

9.  Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

Authors:  Paul Michel Mertes; Marie-Claire Laxenaire; François Alla
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

10.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents.

Authors:  H A Sampson; L Mendelson; J P Rosen
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.